跳至主要内容
临床试验/NCT04232566
NCT04232566招募中不适用

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年2月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
60
试验地点
2
主要终点
Liver fibrosis

研究概览

简要总结

This study is being done to better understand the relationship between inflammation in adipose tissue (AT), abnormal deposition of fat around the liver and how this affects its appearance and function and ultimately insulin resistance.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Undergoing gastric bypass surgery
  • Confirmed AUROC F=0 or F>2 liver fibrosis
  • Age 30-70 years
  • BMI greater than 40 kg/m2
  • Negative pregnancy test (female only)
  • Lab Values: Normal TSH

排除标准

  • Autoimmune diseases
  • Hepatitis B or C positive
  • Heavy alcohol use
  • Active smoking history
  • Active cancer history
  • History of asthma
  • History of COPD
  • Taking Plavix or Coumadin
  • Blood donation within past 2 months
  • Glucocorticoid Therapy
  • Taking antihistamine on regular basis

研究组 & 干预措施

Weight loss surgery

Gastric bypass surgery will be followed by weight loss as standard of care. Liver fibrosis by elastography will be determined before surgery.

干预措施: Bariatric surgery (Procedure)

结局指标

主要结局

Liver fibrosis

时间窗: Baseline

evaluate the liver fibrosis by elastography before surgical intervention

Adipose tissue inflammation

时间窗: Baseline

Evaluate markers of adipose tissue inflammation by mRNA levels

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Elena Anna (Eleanna) De Filippis, M.D., Ph.D.

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验